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ABSTRACT
Concern over the devastating effects of the Human 
Immunodeficiency Virus (HIV) has been met with rigorous 
research efforts by allied health professions. Identifying 
variables, or co-factors, that contribute to the 
progression of HIV has been of increased interest to health 
professionals in recent years. Social scientists as well 
as medical professionals have begun to offer evidence that 
certain psychosocial co-factors are important in predicting 
the health status of HIV-positive individuals.
A few models have been offered to illustrate the 
interrelations among psychosocial co-factors and HIV 
disease. Stress, social support, coping, and mood states 
constitute the most frequently researched variables in this 
area. However, data have been inconclusive and the models 
have not been substantiated empirically.
The present study examined the impact of stress, 
social support, coping and mood on the health status of 
HIV-positive individuals. Correlational data suggested all 
of these psychosocial co-factors were associated with HIV 
symptom count. However, no psychosocial variable (with the 
exception of coping) predicted immune functioning in these 
same individuals. A model was created and supported that 
illustrated the links among these psychosocial co-factors 
and HIV symptoms. The results are discussed with 
implications for future HIV research and treatment.
vii
INTRODUCTION
Over the past decade, awareness of the devastating 
effects of Human Immunodeficiency Virus (HIV), primarily 
with regard to the Acquired Immune Deficiency Syndrome 
(AIDS), has increased exponentially. Unfortunately, AIDS 
awareness among the general population often is transformed 
into misconceptions concerning modes of transmission, 
phobias of HIV-infected individuals, and prejudices against 
high risk groups. In contrast, heightened concern among 
allied health professions is resulting in positive 
endeavors. Educational programs, effective treatments, and 
rigorous research geared toward combatting the disease are 
paving the way toward a final resolution of the HIV crisis.
Social scientists have made significant contributions 
in the fight against HIV. Psychologists were at the 
forefront of planning and implementing an AIDS prevention 
program for the San Francisco area (McKusick, Conant, & 
Coates, 1985). As a result, relative to other high risk 
populations, HIV prevalence among homosexual/bisexuals has 
decreased substantially (Nash & Said, 1992; Winkelstein & 
Padian, 1987). AIDS dementia and the psychological 
sequelae of HIV infection are popular topics on research 
agendas. Additionally, mental health professionals are 
developing and empirically scrutinizing psychological 




The efficacy of psychotherapy has been observed not 
only in attenuating the psychosocial impact of HIV but also 
in treating the physical manifestations of HIV disease 
(Antoni et al., 1991; LaPerriere et al., 1990). Data are 
beginning to emerge to suggest that psychosocial variables 
serve as important co-factors in HIV disease susceptibility 
and progression (Mulder & Antoni, 1992; Solomon, Kemeny, & 
Temoshok, 1991). These recent investigative efforts are 
supported by previous research included under the rubrics 
of psychoimmunology or psychoneuroimmunology (Ader, 1991). 
Research in this area has elevated the understanding of 
immune disorders and provided support for multifactorial 
models of diseases, including HIV (Jemmott & Locke, 1984; 
Livingston, 1988).
Human Immunodeficiency Virus (HIV)
Definition and Epidemiology
The HIV clinical spectrum constitutes the United 
States' primary health concern (Livingston, 1988). A 
number of clinical manifestations are possible, with AIDS 
typically being the end result. The virus was named Human 
T-Cell Lymphotropic Virus Type III (HTLV-III) by the 
National Cancer Institute and Lymphadenopathy -Associated 
Virus (LAV) by a group of French researchers (Fenton,
1987). To prevent confusion, the International Committee
on the Taxonomy of Viruses suggested the inclusive term 
"Human Immunodeficiency Virus (HIV)" (Fenton, 1987).
HIV is a retrovirus, a classification given to viral 
strains capable of transcribing their own genetic material 
into a host cell (Wormser, Stahl, & Bottone, 1987). 
Following invasion of the host cell, HIV's RNA is uncoated 
and transcribed into DNA. The viral DNA is integrated into 
the host cell's nucleus, where it may remain dormant or 
generate buds of genetic material. These buds are released 
from the cell membrane, replicating the virus and leaving 
the host cell to die (Fultz, 1989). Because of its ability 
to lie dormant, HIV is subclassified as a lentivirus. 
Lentiviruses replicate slowly and the resulting clinical 
effects are often latent (Wormser, Stahl, & Bottone, 1987).
Current epidemiological information indicates that 
anywhere from 900,000 to 2 million people in the U.S. are 
HIV positive. As of December, 1992, over 253,448 cases of 
AIDS had been reported in the U.S. while 611,589 cases were 
reported worldwide (Centers for Disease Control Statistics, 
1992) . High risk adult populations include 
homosexual/bisexual males (60%), intravenous drug users 
(21%), homosexual/bisexual male intravenous drug users 
(7%); heterosexuals (5%), transfusion/tissue recipients 
(2%), hemophiliacs (1%) and others/undetermined (4%) (Nash 
& Said, 1992). There is an uneven ethnic distribution of 
AIDS. Minority groups, namely African-American (30% of
U.S. cases) and Hispanic (17% of U.S. cases), are 
represented in greater proportions. Eleven percent of U.S. 
cases are females. Misconceptions concerning potential 
modes of HIV infection are ubiquitous. However, data 
indicate that only blood, semen, and vaginal fluid contain 
significant enough portions for transmission (Centers for 
Disease Control Statistics, 1993; Fernandez & Ruiz, 1989; 
Scutchfield & Benenson, 1989).
Pathophysiology
HIV pathogenesis typically begins with altered immune 
functioning. Traditionally, immune functioning has been 
delineated into two categories, cellular immunity and 
humoral immunity (Wormser et al., 1987). Cellular immunity 
is the category primarily affected by HIV. Two types of 
cells, helper (T4 or CD4) T-lymphocytes and suppressor (T8 
or CD8) T-lymphocytes, regulate cellular immunity. These 
cells are produced by lymphoid tissue and mature in the 
thymus (DeVita, Heilman, & Rosenberg, 1985; Dixon & Fisher,
1983). Both the total CD4 count and the CD4/CD8 ratio 
provide the signals for a variety of immune processes. HIV 
destroys CD4s and disrupts the critical CD4/CD8 ratio, 
leaving an individual's immune system compromised (DeVita, 
Heilman, & Rosenberg, 1985).
Alterations in immune functioning are evident at a 
number of levels. Several principle changes in cellular 
immunity occur. First, the number of lymphokines (e.g.,
interleukins 1 and 2, gamma-interferon) is depleted. 
Lymphokines regulate the activity of other immune 
substances, mainly phagocytes and natural killer (NK) 
cells. Both phagocytes and NK cells attack and eliminate 
invading foreign substances (antigens) that initiate 
infection and disease. Second, this reduction in 
lymphokines is paralleled by compromised ability and 
decreased proliferation of both phagocytes and NK cells. 
Finally, as these immune substances are eliminated, the 
individual becomes susceptible to a variety of 
opportunistic infections and diseases (DeVita, Heilman, & 
Rosenberg, 1985; Dixon & Fisher, 1983; McDougal et al., 
1991).
CD4 count and the CD4/CD8 ratio also signal important 
humoral immune processes, namely the production and release 
of antibodies via B-lymphocytes (lymphocytes that mature in 
bone marrow). As helper T-lymphocytes are destroyed by 
HIV, the organism fails to produce certain antibodies that 
destroy antigenic agents (DeVita, Heilman, & Rosenberg, 
1985; McCutchan, 1990) while other antibodies (e.g., 
gammaglobulin) may be elevated (McDougal et al., 1991). 
Although hypergammaglobulinemia occurs, there is a poor 
antigen-specific response of the circulating antibodies due 
to immunodepression (McDougal et al., 1991).
As HIV induces the cascade of immunological deficits, 
disease manifestations develop over time. However, HIV
symptomatology is highly unpredictable and sometimes 
transient, making disease course variable among infected 
individuals (Rogers & Masur, 1989). The Centers for 
Disease Control (CDC) has developed a four-point 
classification system of HIV disease (Rogers & Masur,
1989). Type I is associated with acute infection. Recent 
studies have indicated that a mononucleosis-like syndrome 
with a duration of approximately two-three weeks is common, 
but not always present, following acute infection. This 
syndrome is characterized by fever, diaphoresis, lethargy, 
muscle ache, headache, and sore throat (Cooper et al.,
1985).
Asymptomatic individuals comprise the type II 
classification, while type III classification is 
characterized by persistent generalized lymphadenopathy 
(PGL; Rogers & Masur, 1989). PGL is diagnosed when two 
lymph node sites, other than the groin area, remain swollen 
for at least one month (Bartlett & Finkbeiner, 1991). 
Although frequently considered an ill-defined syndrome, 
many individuals with PGL exhibit additional symptoms 
constituting AIDS-Related Complex (ARC). ARC is 
characterized by lymphadenopathy, fever, weight loss, and a 
reduction in both red and white blood cells. Signs and 
symptoms of ARC include shortness of breath, persistent 
cough, yeast infections, diarrhea, night sweats, fatigue, 
and malaise. Persons with ARC may display the entire
spectrum of clinical manifestations or a select few 
(Badgley, 1987).
Type IV classification of HIV disease is AIDS (Rogers 
& Masur, 1989). AIDS is diagnosed when an infection or 
disease develops in an HIV-positive individual. The most 
common diseases associated with AIDS are Pneumocystis 
carinii pneumonia (present in 60% of U.S. adult cases), 
oral/pharyngeal candidiasis (present in 45% of U.S. adult 
cases) and Kaposi's Sarcoma (present in 10%of U.S. adult 
cases). Other diseases commonly associated with AIDS 
include cryptococcosis, cytomegalovirus, Mycobacterium 
avium complex, herpes zoster, herpes simplex, 
cryptosporidiosis, tuberculosis, immunoblastic sarcoma, and 
toxoplasmosis (Nash & Said, 1992).
The progression from HIV seroconversion to AIDS is not 
well understood and varies a great deal among infected 
individuals (Rogers & Masur, 1989; Scutchfield and 
Benenson, 1989). Duration of infection has been the only 
consistent predictor of disease progression (McDougal et 
al., 1989). Sonnabend, Witkin, and Purtilo (1984) were 
among the first authors to ascribe importance to possible 
HIV co-factors in their "immunological overload" 
hypothesis. Repeated exposure to HIV, excessive drug use, 
poor nutrition, aberrant health practices, and presence of 
other viral pathogens present chronic challenges to 
immunocompetence. These constant insults "overload" the
immune system, leaving the individual susceptible to HIV 
infection and HIV illness progression (Levy & Ziegler, 
1983; Sonnabend, Witkin, & Purtilo, 1984). Other 
hypothesized co-factors include premorbid immune system 
competency, lifestyle, therapies, and psychological 
variables (Livingston, 1988; McDougal et al., 1989). 
Treatment
Treatment for HIV is in the experimental stage. The 
most popular treatment thus far has been zidovudine 
(azidothymidine or AZT), an antiviral agent that slows HIV 
replication. AZT has a number of untoward side effects 
(e.g., bone marrow suppression and anemia).
Dideoxycytidine (ddC) and dideoxyinosine (ddl) constitute 
another class of antivirals similar to AZT. Although 
clinical trials have reported some efficacy in slowing the 
viral replication, peripheral neuropathy is a common side 
effect of ddl and ddC (Cohen, Sande & Volberding, 1990). 
Other experimental treatments are becoming rapidly 
available. However, concern over their toxicity and 
efficacy deters the accessibility of these interventions 
(DeVita, Heilman, & Rosenberg, 1985). Other treatment 
options commonly employed by HIV patients include physical 
rehabilitation (Mukand, 1991), psychotherapy (Kelly & St. 
Lawrence, 1988), and alternative therapies (Badgley, 1987)
9
Psychosocial Factors Associated with HIV
In addition to the numerous medical complications 
associated with HIV infection, the psychological sequelae 
presents a significant complicating factor throughout the 
HIV clinical spectrum. Even among seronegative individuals 
in high risk categories, high rates of psychological 
distress have been observed. Clinical features identified 
among these "worried well" include panic, anxiety, 
obsessions, compulsions, somatization, hypochondriasis, 
substance abuse, depression, and bereavement (Faulstich, 
1987; Perry, Jacobsberg, Fishman, 1990).
Following infection, up to 90% of all HIV patients may 
suffer psychological and/or neuropsychological 
complications (Fernandez & Ruiz, 1989). According to 
Fernandez and Ruiz (1989), mental status impairment in HIV 
likely results from one (or a combination) of the 
following; "1. direct HIV infection of the brain; 2. a 
secondary brain infection by an opportunistic organism; 3. 
an emotional reaction to illness; 4. an unrelated 
psychiatric disorder, previously or newly diagnosed." 
Psychopathology can manifest at any stage of HIV disease. 
Some studies have demonstrated that higher rates of 
psychological distress occur during earlier rather than 
later stages of HIV infection, when uncertainty about 
prognosis is heightened (Temoshok, 1986; Tross et al.,
1986) .
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Anxiety and depression constitute the most frequently 
identified psychological symptoms among persons with HIV 
(Holland & Tross, 1985). Common fears include prognostic 
uncertainty, imminent death, infecting others, ostracism, 
and a pervasive feeling of lost control. Up to 30% of HIV 
patients experience clinical levels of depression. Suicide 
rates may exceed those of the general population by up to 
66 times (Marzuk et al., 1988). Psychiatric morbidity is 
common, with the most frequent diagnoses being (in order of 
prevalence) adjustment disorder, major depression, 
delirium, dementia, treatment-related side effects, and 
premorbid psychiatric or personality disorder (Holland & 
Tross, 1985).
Neuropsychological deficits are pervasive among HIV 
patients, with AIDS dementia complex (also referred to as 
HIV dementia) being the most common neurological syndrome 
among HIV patients (Navia & Price, 1987). Prevalence 
estimates of AIDS dementia range from eight to 66% in 
individuals diagnosed with AIDS (Maj, 1990). Research has 
indicated that cognitive impairment may be the sole or 
presenting feature of AIDS in a large percentage of 
patients (Navia & Price, 1987). Impairments in memory, 
concentration, attention, and speed of cognitive processing 
as well as decreased motor performances (e.g., ataxia, 
hyper-reflexia, coordination difficulties, and dysarthria) 
are frequently observed (Maj, 1990). Treatment outcome
11
studies have shown that cognitive deficits can be 
successfully managed with AZT (Maj, 1990).
Psychological Co-factors in HIV Disease 
A more recent focus of psychosocial investigations 
concerning HIV has been the impact of psychological 
variables on HIV disease status. An interactive model 
explaining HIV susceptibility purports that biological and 
psychosocial variables combine to leave an individual 
immunosuppressed and vulnerable to HIV infection 
(Livingston, 1988). Interaction models explain not only 
susceptibility to infection but also progression of the HIV 
clinical continuum (Livingston, 1988). A number of 
psychosocial variables have been implicated by interaction 
theorists including classical conditioning, mood, stress, 
social support, coping, and personality.
Conditioning
In recent years, researchers have suggested that 
immune processes can be classically conditioned. Animal 
studies have indicated that both immune suppression (Ader, 
1985) and immune enhancement (Ghanata, Hiramoto, Solvason,
& Spector, 1985; Gorczynski, Macrae, & Kennedy, 1982) are 
capable of being conditioned. To date, one human study 
exists that examined conditioning of the immune response. 
Smith and McDaniel (1983) conditioned an allergenic 
hypersensitivity response among tuberculin-positive
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individuals. Taken together, these studies provide limited 
evidence that immune processes can be classically 
conditioned. Aside from the paucity of data, a primary 
limitation concerns anthropomorphism. Differences in 
animal and human immune systems are clearly evident (Dixon 
& Fisher, 1983). More human studies that include HIV 
populations are necessary before definite conclusions can 
be reached.
Despite these limitations, a number of authors 
(Baumgartner, 1985; Coates, Temoshok, & Mandel, 1984; 
Kiecolt-Glaser & Glaser, 1988) have proposed that HIV 
susceptibility and clinical course can be conditioned and 
have cited the aforementioned studies to support their 
claims. Basically, the conditioning model proposes that 
conditioned learning leads to immunosuppression which 
leaves the individual vulnerable to infection when exposed 
to HIV. Repeated occurrence of conditioned behaviors 
facilitates HIV illness progression (Baumgartner, 1985; 
Coates, Temoshok, & Mandel, 1984; Kiecolt-Glaser & Glaser, 
1988) . These authors do not clearly identify stimuli and 
responses in their models. Coates, Temoshok, and Mandel 
(1984) suggest that an environmental stressor 
(unconditioned stimulus) leads to immunosuppression 
(unconditioned response). Reactivated internal states 
(e.g., anxiety) associated with the stressor become the 
conditioned stimulus and promote further immunosuppression
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(conditioned response), resulting in HIV disease 
progression or increased susceptibility to HIV infection 
(second-order conditioned responses).
Mood
In addition to conditioning, researchers have been 
interested in the impact of affective states on physical 
and psychological well-being of HIV patients (Baum & 
Nesselhof, 1988? Chuang, Devins, Hunsley, & Gill, 1989). 
Evidence for a relation between altered mood and immune 
functioning has been well documented in the literature. 
Bereavement has been associated with decreased lymphocyte 
responsivity (Bartrop, Lockhurst, Lazarus, Kiloh, & Penny, 
1977; Schleifer, Keller, McKegney, & Stein, 1979) and 
impaired NK activity (Kiecolt-Glaser et al., 1984).
Patients with major depression have demonstrated a 
deficiency in T-lymphocyte responsivity and lowered levels 
of T-helpar cells (Calabrese, Kling, & Gold, 1987; 
Kiecolt-Glaser et al., 1984). Severity of depression also 
has been correlated significantly with reduced NK 
cytotoxicity (Irwin, Daniels, Bloom, & Weiner, 1986).
The previously described studies suggest that 
bereavement and depression alter immunity. Few studies, 
however, have examined mood variables as they relate to the 
HIV illness process. In a clinical narrative, Laudenslager 
and Reite (1984) cited evidence for HIV illness progression 
resulting from bereavement in a 42-year-old HIV-positive
14
male. Solomon and Temoshok (1987) reported preliminary 
findings of their longitudinal study examining mood 
variables and immune functioning in individuals with HIV. 
Among ARC subjects, increased hostility predicted quicker 
mortality. Dysphoria and anxiety were correlated with 
leukocytes, indicating possible higher incidence of 
opportunistic infections in psychologically distressed 
individuals with ARC (Solomon & Temoshok, 1987).
As part of the Multicenter AIDS Cohort Study, Ostrow 
et al. (1989) administered the Center for Epidemiological 
Studies Depression (CES-D) Scale (Radloff, 1977) to nearly 
5,000 homosexual men. Depression was positively associated 
with lymphadenopathy and prevalence of HIV-related 
symptoms. Zich and Temoshok (1987) reported similar 
findings in their comprehensive study of psychosocial 
functioning and HIV symptoms. Total number of HIV-related 
symptoms was correlated with self-reported depression and 
anxiety in 50 men diagnosed with AIDS. However, no mood 
effects were obtained in the sample of ARC patients.
In their investigation of 113 HIV-positive gay men, 
Gorman et al. (1991) examined correlations among 
depression, anxiety, T-cell counts, urinary cortisol, and 
overall health. Cortisol level was correlated 
significantly with health status, depression, and anxiety 
in a positive direction. However, the effects were small,
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and nonsignificant associations were found with immune 
parameters.
Stress
A popular theme in behavioral medicine has been the 
study of stress and its relationship to health. Hans Selye 
(1950) stimulated much of the interest in stress research 
with identification of the "General Adaptation Syndrome 
(GAS)." Stress research has become more sophisticated over 
the past four decades, allowing specialty fields to 
emerge. The emergence of psychoneuroimmunology has 
directed recent investigative efforts toward uncovering a 
nexus between stress and the immune system. This work has 
important implications for diseases of the immune system, 
HIV-related illnesses in particular.
Livingston (1988) proposed a model to explain how 
stress contributes to immunosuppression and susceptibility 
to AIDS. In this "sociopsychophysiologic" model, life 
situations are referred to as stressors and a response to 
the events is referred to as stress. According to 
Livingston (1988), stress occurs when an individual's 
assessment of a stressor overwhelms his or her "Filter 
Resource Capability System (FRCS)." That is, the 
individual's perceived capabilities are not sufficient to 
deal with the event. In discussing his model, Livingston 
(1988) stated that stress suppresses an individual's immune
16
functioning, leaving him or her susceptible to 
opportunistic infection.
Supporters of a stress approach to HIV susceptibility 
have pointed out that the stressors faced by high risk 
groups (e.g., gay men and drug abusers) may be greater than 
those of the general population (Cecchi, 1984; Livingston, 
1988). Cecchi (1984) regards stress as the most probable 
determining factor to explain why gay men are more 
susceptible to AIDS than heterosexuals. Potential 
stressors encountered by high risk, HIV-negative 
individuals include fear of contracting HIV, discrimination 
and stigmatization by the public, multiple bereavements, 
and sexual curtailment. Moreover, stress is likely to 
increase following HIV infection. Lack of empathy and 
support from the general and medical communities, disbelief 
in medical technology to find a cure or preventive measure, 
and financial difficulties make up only a few burdens faced 
by seropositive individuals (Cecchi, 1984; Livingston,
1988) .
Stress models of HIV disease status are supported by 
research demonstrating that chronic stress causes changes 
in the body's neuroendocrine pathways. These changes are 
mediated primarily by the hypothalamic-pituitary-adrenal 
cortex axis and the sympathetic adrenal-medullary system. 
During periods of stress, the adrenal cortex secretes 
steroids, primarily cortisol, while the adrenal medulla
17
produces catecholamines. Both corticosteroids and 
catecholamines can produce secondary changes in immune 
functioning.
A group of researchers at the Center for the 
Biopsychosocial Study of AIDS (Antoni et al., 1990) 
recently has begun to examine the effects of hormones and 
catecholamines as they relate to stress and HIV. From
their work, these investigators support the notion that two
stress response patterns exist. The first pattern, 
referred to as "active coping," occurs when an individual 
has adequate coping resources to meet the demands of the 
stressor. Active coping is mediated by the
sympathoadrenalmedullary system. Early evidence for this
biologically mediated coping mechanism is based in Cannon's 
(1926) classic description of the flight or fight 
response.
During active coping, the perception of stress causes 
electrochemical changes in the brainstem. These changes 
result in sympathetic arousal, mediated by the autonomic 
nervous system, throughout the organism. During this 
arousal period, there is a release of epinephrine and 
norepinephrine by the adrenal medulla (Jemmott & Locke,
1984). Hyperarousal of the sympathoadrenalmedullary system 
results in elevated catecholamines and, subsequently, 
immunosuppression (Antoni et al., 1990; McCabe & 
Schneiderman, 1985). Recent investigations have
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demonstrated that catecholamine receptors are present on 
lymphocytes (Borysenko & Borysenko, 1982). Stimulation of 
these receptors decreases lymphocyte metabolism, 
proliferation, and antibody secretion (Strom, Lundin, & 
Carpenter, 1977) and reduces NK cell cytotoxicity (killing 
ability) (Antoni et al., 1990).
A second pattern of behavioral responding occurs when 
no coping response is available when confronting a 
stressor. Evidence for this type of responding can be 
found in Selye's (1950) original GAS work. When the 
individual does not have adequate coping resources, 
hypervigilance and/or withdrawal may occur. These 
behaviors activate the hypothalamic-pituitary 
adrenocortical (HPAC) system. Activation of this system 
begins as the cortex and limbic system signal the 
hypothalamus to release corticotropin releasing factor 
(CRF). CRF causes the pituitary to release 
adrenocorticotropin hormone (ACTH) which, in turn, signals 
the release of corticosteroids by the adrenal cortex 
(Jemmott & Locke, 1984).
Specific immune changes parallel the release of CRF, 
ACTH, and corticosteroids (Antoni et al., 1990). CRF, 
using cyclic AMP as its second messenger, inhibits the 
cytotoxicity of NK cells. ACTH disrupts the intracellular 
level of calcium in T-lymphocytes, impairing their 
responsiveness. Corticosteroids cause an array of
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alterations in immune capacity. Cortisol binds with 
receptors located on T-lymphocytes. Chronic elevations of 
cortisol and other corticosteroids lead to thymus 
shrinkage, a decrease in circulating T-lymphocytes, and a 
reduced ability of lymphocytes to ward off infectious 
agents (Claman, 1972; Livingston, 1988).
Markham, Salahuddin, Veren, Orndorff and Gallo (1986) 
provided laboratory evidence that stress-related hormones 
can lead to HIV susceptibility. These researchers 
supplemented in vitro cultures of normal T-lymphocytes with 
corticosteroids (mainly hydrocortisone). The cultures were 
then exposed to HIV. The ability of HIV to infect cells 
was enhanced significantly when the cultures contained 
corticosteroids. These authors concluded that individuals 
under stress may be more vulnerable to HIV infection 
(Markham et al., 1986) .
Gorman et al. (1991), however, failed to find any 
association between stress-related hormones and immune 
functioning in 112 HIV positive males. Subjects collected 
urinary free cortisol samples over a 24-hour period.
During the same period, they underwent a battery of medical 
and psychological tests. These investigators examined 
correlations between urinary cortisol levels and CD4s,
CD8s, and CD4/CD8 ratios. No significant findings were 
observed.
In the Gorman et al. (1991) study, however, cortisol 
was significantly correlated with physician-rated HIV 
disease progression and number of HIV-related symptoms. 
Cortisol levels also significantly correlated with scores 
on both the Hamilton anxiety and depression scales in 
positive directions. Although no direct link between 
stress and immune functioning was obtained, these authors 
concluded that stress (via stress-related hormones, i.e. 
cortisol) may impact the global health status of HIV 
patients. Moreover, the authors strongly encouraged 
expeditious delivery of mental health services to HIV 
patients (Gorman et al., 1991).
By comparing HIV to other retroviruses, the impact of 
stress on HIV disease progression has been addressed 
hypothetically. Kiecolt-Glaser and Glaser (1988) 
hypothesized that stress affects HIV progression similar to 
the way it affects herpesvirus progression. That is, 
stress triggers the virus to change from a latent to a 
symptomatic clinical state. Data has suggested that 
academic stress increases antibodies to the Epstein-Barr 
virus, herpes simplex virus type 1, and cytomegalovirus 
among medical students (Glaser et al., 1985).
Kiecolt-Glaser and Glaser (1988) also reported evidence 
that herpesvirus antibody production can result from 
multiple sources of stress including marital separation and 
caregiving.
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In a similar vein, Robertson et al. (1990) examined 
the correlation between psychological distress and herpes 
simplex in HIV patients. These investigators found 
significant positive correlations between level of distress 
and titers to herpes simplex among their 50 HIV positive 
subjects. They concluded that reactivation of herpes 
simplex facilitates HIV disease progression. No studies, 
however, have directly addressed the hypothesis that stress 
disinhibits the latent nature of HIV.
A noteworthy stressor encountered by all HIV positive 
individuals concerns the HIV testing and notification 
process. Anticipating the results of one's antibody status 
following HIV testing can create inordinate levels of 
stress. Ironson et al. (1990) examined relations between 
immune parameters and distress following HIV testing. A 
significant negative correlation was found between anxiety 
at the time of notification and NK cytotoxicity one week 
later in 14 HIV positive men. In addition, changes in 
scores on the avoidance scale of the Impact of Events Scale 
(Horowitz, Wilner, & Alvarez, 1979) also negatively 
correlated with NK cytotoxicity over the same period.
These authors concluded that individual differences in 
stress reactions to HIV notification may affect HIV 
immunocompetence (Ironson et al., 1990).
Research supporting the hypotheses that stress and 
mood influence the clinical course of HIV is promising.
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However, most researchers would agree that neither stress 
nor mood alone is sufficient to explain psychologically 
mediated HIV susceptibility and progression.
Multifactorial models provide a comprehensive approach in 
describing the impact of psychological variables on the HIV 
clinical spectrum (Livingston, 1988). In addition to 
stress and mood, multifactorial models present potential 
moderating variables associated with illness. Among the 
most frequently mentioned moderators of HIV are social 
support, coping style, and personality.
Social Support
Social support as an intermediate or mediating 
variable has received a great deal of attention in health 
psychology research. Evidence that social support 
"buffers" the effect of stress on health, both physical and 
mental, has been well documented in the literature (Cohen & 
Wills, 1985). Only a few studies, however, have examined 
the potential influences of social support on HIV 
symptomatology.
Zich and Temoshok (1987) examined the direct effects 
of social support on HIV-related symptoms. In their 
cross-sectional study of over 100 HIV-positive individuals, 
these investigators reported that the total availability of 
social support had a significantly negative correlation 
with reported physical symptoms. Physical symptoms were 
divided into two categories, "hard" symptoms (e.g.,
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infections and anemia) and "soft" symptoms (e.g., insomnia 
and weight loss). Both categories were associated with a 
lack of social support availability (Zich & Temoshok,
1987) .
In the previously discussed stress model by Livingston 
(1988), the importance of social support briefly is 
considered. A number of variables are purported to 
comprise the Filter Resource Capability System (FRCS), 
including social support. Although the ability of social 
support to serve as a stress buffer has been supported 
elsewhere, Livingston (1988) offers no empirical data to 
demonstrate the importance of social support in HIV 
infected individuals.
In their preliminary results, Solomon and Temoshok 
(1987) reported data linking social support and AIDS 
progression. These investigators compared the availability 
of social support in a deceased group of AIDS patients to a 
surviving group. Scores were obtained on a number of 
social support dimensions. Survivors had higher levels of 
available problem-solving assistance than deceased 
victims. This finding was representative only of 
Pneumocystis carinii pneumonia patients. No differences in 
mortality rates attributable to social support were found 
for Kaposi's sarcoma or ARC patients (Solomon & Temoshok, 
1987) .
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Reillo (1990) also considered social support an 
important prognostic indicator in a study of 58 AIDS 
patients. In this study, the author attempts to construct 
a profile of AIDS patients at risk for early mortality.
Lack of social support, in combination with African- 
American race and a high level of psychological distress, 
was highly predictive of demise at 12 months among the 
subjects (Reillo, 1990) .
Coping
Coping and personality style both have received 
empirical support as moderating variables and stress 
buffers in HIV disease (Livingston, 1988; Solomon,
Temoshok, O'Leary, and Zich, 1987; Zich & Temoshok, 1987). 
The concept of "hardiness" as both a personality trait and 
coping strategy has been addressed in a few HIV studies. 
Kobasa, Maddi, and Courington (1980) refer to hardiness as 
a combination of "challenge, commitment, and control." It 
is frequently defined as an enduring personality trait 
characterized by coping ability and adaptivity.
Solomon and Temoshok (1987) reported that hardiness 
was negatively correlated with total lymphocyte count in 
AIDS and ARC subjects. These authors speculated that 
deficits in hardiness are associated with a greater number 
of secondary infections. Additional significant findings 
were reported for subscales measuring commitment and 
control. Higher scores on the commitment scale predicted
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survival among ARC patients. Likewise, mortality rates for 
AIDS patients were lower for individuals with higher 
control scores (Solomon & Temoshok, 1987). Temoshok, 
O'Leary, and Jenkins (1990) reported similar data for their 
15 subjects. Hardiness composite score, in addition to 
positive affect and heart rate reactivity, significantly 
predicted AIDS survival time.
Fletcher et al. (1989) also assessed coping style and 
hardiness in 24 HIV positive males. They charted the onset 
of HIV-related illness in their subjects for 1 to 2 years. 
When compared, subjects who remained asymptomatic 
throughout the study had significantly higher active 
coping, overall hardiness, and hardiness-commitment scores 
than those who developed medical complications. From their 
results, Fletcher et al. (1989) concluded that psychosocial 
variables may be important contributing factors in HIV 
illness progression.
In their prospective studies on immune changes and 
psychological distress following HIV status notification, 
Antoni et al. (1990) assessed coping strategies. Subjects 
completed the COPE inventory (Carver, Scheier, & Weintraub, 
1989) at baseline. These investigators particularly were 
interested in denial as a coping mechanism. Scores on the 
denial subscale of the COPE were correlated significantly 
with lymphocyte proliferation responses to 
phytohemagglutinin antigen (Antoni et al., 1990). These
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findings suggest that denial may constitute a poor coping 
strategy when preparing for serostatus notification 
following HIV testing.
Personality
In the ongoing Biopsychosocial AIDS Project, 
researchers are studying the association between 
personality variables and the HIV clinical spectrum 
(Solomon & Temoshok, 1987). Hypotheses are emerging that 
suggest an "immunosuppression-prone" personality exists. 
Profiles of these individuals emphasize "compliance, 
conformity, self-sacrifice, denial of hostility or anger, 
and non-expression of emotion" (Solomon & Temoshok, 1987). 
This personality type may resemble the "Type C" personality 
which predicts susceptibility to cancer and a relatively 
poor prognosis (Morris, 1982). Personality theories 
concerning immunosuppression are purely speculative at this 
point. No research supporting these theories with 
reference to HIV susceptibility has been reported.
Relevant Treatment Outcome Research
Clinical researchers have demonstrated that immune 
functioning can be enhanced by psychological treatments 
(Jemmott & Locke, 1984; Kiecolt-Glaser, 1988). Thus, 
mental health professionals have been quick to recognize 
the potential efficacy of psychological interventions in 
the treatment of HIV. Treatments for HIV have ranged from 
group therapy to cognitive-behavioral therapy to
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metaphysical and alternative therapies (Badgley, 1987;
Hand, 1989; Kelly & St. Lawrence, 1986). Although these 
treatments are becoming routine, reported treatment outcome 
studies have been sparse.
A group of researchers at the Center for the 
Biopsychosocial Study of AIDS in Miami recently began a 
series of studies on the efficacy of stress reduction as a 
potential treatment for HIV illness (Antoni et al., 1990). 
These investigators are examining the effects of cognitive- 
behavioral therapies, stress management, and aerobic 
exercise training on immunocompetence in individuals with 
HIV. Preliminary results suggested that both seropositive 
and seronegative individuals had increased T-helper counts 
following 10 weeks of aerobics training. In addition, 
aerobics significantly reduced psychological distress in 
HIV-infected men compared to nontreatment seropositive 
controls (Antoni et al., 1990). Results of the stress 
management condition are forthcoming.
Additionally, the same group of researchers found that 
these psychotherapeutic treatment strategies buffered the 
affective distress and immune decrements associated with 
HIV testing (Antoni et al, 1991; LaPerriere et al., 1990). 
In a study of 50 HIV positive men, individuals who 
participated in aerobics training had neither marked 
emotional distress nor significant deficiency in NK cell 
count upon serostatus notification. Seropositive controls
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who received no treatment, however, displayed clinical 
levels of anxiety and depression as well as a significant 
reduction in NK cells following notification of their HIV 
status (LaPerriere et al. 1990).
Antoni et al. (1991) reported similar findings with a 
stress management intervention. Forty-seven men either 
received an assessment-control condition or stress 
management condition prior to notification of their HIV 
status. In the treatment condition, cognitive-behavioral 
strategies (assertiveness training, cognitive 
restructuring, relaxation, and behavioral rehearsal) were 
implemented. Subjects in the treatment condition 
demonstrated significant elevations in CD4 and NK cell 
counts and in proliferative responses to phytohemagglutinin 
at postnotification of HIV status. HIV positive subjects 
in the control condition significantly differed from 
experimental subjects and displayed decreases in immune 
parameters following notification. In addition, a 
reduction in depression was correlated with relaxation 
practice among experimental subjects. These authors 
concluded that stress management buffered the emotional 
reaction and immunological compromise associated with HIV 
testing and notification (Antoni et al., 1991).
PURPOSE OF THE STUDY 
Research examining psychosocial factors as they relate 
to HIV is in its infancy. Many of the existing studies 
rely heavily on data concerning immune patterns in non-HIV 
populations. From the available data, however, preliminary 
evidence suggests that potential psychological co-factors 
in HIV disease may exist. Stress, coping, social support, 
and mood constitute the most empirically supported co­
factors thus far. A few authors (Antoni et al., 1990; 
Livingston, 1988) have offered hypothetical models to 
illustrate the relations among some of these variables and 
HIV. However, no study has attempted to investigate these 
variables in an integrated fashion.
In the present study, a model (see Figure 1) was 
proposed based on previous data. Major stress (e.g., job 
loss, death of a loved one) and minor stress (e.g., car 
trouble, argument with spouse) were included as two 
separate constructs in the proposed model. Contemporary 
stress researchers recognize this conceptual delineation 
and have reported that major and minor stress 
differentially impact health status. Data have been 
offered to suggest that minor stress has a greater impact 
on illness fluctuations than major stress (Brantley &
Jones, 1989, Delongis et al., 1982).
The combined impact of stress and social support on 
mental and physical well-being, commonly referred to as the
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"buffering hypothesis," has been given noteworthy attention 
in health psychology literature (Cohen, 1988; Cohen &
Wills, 1985). Likewise, coping style may alter the impact 
of stress (Lazarus & Folkman, 1984). Coping and social 
support, therefore, were hypothesized to be possible 
mediators of stress in the proposed model.
Mood (or distress) has been considered an outcome or 
function of stress, social support, and coping (Cohen & 
Willis, 1985; Folkman & Lazarus, 1984). In contrast, 
current studies on HIV have indicated that mood may be a 
predictor of HIV disease status (e.g., Ostrow et al, 1989). 
Thus, mood has been included as an intermediate variable in 
the proposed model.
In the existing studies of psychological influences on 
HIV, a number of methodological problems are evident.
First, sample sizes are small in many of the studies. 
Second, virtually all of the subjects have been young 
adult, homosexual/bisexual males. Given that HIV 
prevalence rates are decreasing in homosexual males while 
rising in other risk groups (Nash & Said, 1992), the 
generalizability of these data is limited. Third, most of 
research has been conducted in large U.S. cities where the 
availability of resources for HIV and prevalence rates are 
greatest. Finally, a few studies have failed to discover 
significant links between HIV disease with stressful life 
events (Coates, McKusick, Kuno, & Stites, 1989; Kessler et
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al., 1991), mood (Van Griensven et al., 1989), or social 
support (Van Griensven et al., 1989). The present study 
attempted to address the methodological shortcomings of 
previous studies by including a heterogenous sample of 
adequate size.
In summary, the primary purpose of the present study 
was to provide empirical support for the proposed model and 
thus create a broader understanding surrounding the links 
among psychosocial co-factors and HIV disease. From the 
study, the following questions were addressed:
1. Does stress impact HIV disease status? It was 
hypothesized that stress levels significantly would predict 
HIV disease parameters.
2. Do major stress and minor stress differentially impact 
HIV disease status? It was hypothesized that major stress 
and minor stress, separately, would contribute significant 
amounts of variance to HIV disease parameters.
3. Does social support impact HIV disease status? It was 
hypothesized that social support availability significantly 
would predict HIV disease parameters.
4. Does coping impact HIV disease status? It was 
hypothesized that problem-focused coping significantly 
would predict HIV disease parameters.
5. Does mood impact HIV disease status? It was 
hypothesized that negative affective states significantly 
would predict HIV disease parameters.
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6. Do stress, social support, and coping impact mood among 
individuals with HIV? It was hypothesized that stress 
levels, social support availability, and problem-focused 
coping style would contribute significant amounts of the 
variance to affective distress.
7. What are the interrelationships among stress, social 
support, coping, mood, and HIV disease status? After 
controlling for degree of disease progression, it was 
hypothesized that the proposed structural equations model 























One hundred HIV-positive volunteers were recruited 
from the Early Intervention Clinic at Louisiana State 
University Medical Center-Baton Rouge and Los Angeles 
County-University of Southern California Medical Center's 
AIDS clinic to participate in the study. All adult, 
registered patients at the clinics were eligible to 
participate. Patients who were unable to read English or 
who had a history of dementia or psychosis were excluded 
from the study. Nearly all patients scheduled to have lab 
work completed on days when experimenters were present were 
invited to participate. While exact numbers were not 
documented, only a small percentage of available patients 
were excluded or refused to participate.
Demographic data on subjects are summarized in Tables 
1 and 2. Eighty male and 20 female adults completed the 
study. Mean age was 37, with a range of 18 to 54 years. 
Racial breakdown occurred as followss 59% African-American, 
33% Caucasian, 7% Hispanic, and 1% Native-American. Years 
of education ranged from six to 21, with a mean of 12. The 
sample was of low socioeconomic status, with 86 percent of 
the sample having a yearly income less than $10,000.
Sample demographics were highly similar across data 
sites for age, education, and socioeconmic status (see 
Table 2). Two noteworthy differences were observed with
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regard to sex and race. A larger percentage of women were 
included in the Baton Rouge sample while a substantial 
number of Hispanics participated in the Los Angeles sample. 
In addition, the majority of subjects were from Baton Rouge 
(n=77, versus n=23 from Los Angeles).
All subjects were ambulatory outpatients, receiving 
medical treatment for HIV. A wide range of HIV-related 
illness was displayed among the subjects. The average 
length of time since testing HIV-positive was 25.4 months, 
with a range of zero to 120 months. CD4 counts ranged from 
two to 1089, with a mean of 356.
Measures
The Social Readjustment Rating Scale
(SRRS; Holmes & Rahe, 1967). The SRRS is a 43-item 
self-report questionnaire designed to assess the degree of 
adjustment associated with recent major life events. A 
weighting is assigned to each item, a priori, according to 
the amount of life change (positive or negative) associated 
with the event. Weightings are summed to generate the SRRS 
total score. The weightings were derived from a series of 
scaling studies on a sample of 394 subjects with a wide 
range of demographics. Subjects' ratings of the events 
yielded a high coefficient of concordance (W=.48, p=.0005).
The SRRS is the oldest and one of the most frequently 
employed major stress scales. A great deal of evidence
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supporting its psychometric quality has been offered 
(Miller, 1989). In addition, research has indicated that 
elevated scores on the SRRS predict the onset of various 
medical and psychiatric disorders (Miller, 1989).
The Weekly Stress Inventory
(WSI; Jones & Brantley, 1989). The WSI is an 87-item, 
self-report scale measuring stressful events a person is 
likely to experience throughout the week. Items are rated 
on a Likert-type format, ranging from 0 ("did not occur") 
to 7 ("most stressful"). Three scores are generated from 
the WSI. These include an Event score (WSI-E; the number 
of items endorsed), an Impact score (WSI-I; the sum of all 
item ratings), and an I/E ratio score. The WSI-I was used 
in the present study.
Adequate concurrent validity (.61) and test-retest 
reliability (.6) of the WSI have been demonstrated. A 
principal components analysis yielded one construct with an 
alpha coefficient of .95, indicating that the items 
consistently measure the same construct ("stress") (Jones & 
Brantley, 1992). In a study of 100 cardiac patients, the 
WSI significantly predicted pain and physical symptoms 
(Mosley & Brantley, 1989; unpublished data).
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The Interpersonal Support Evaluation List
(ISEL; Cohen, Mermelstein, Kamarck, & Hoberman, 1985). 
The ISEL is a 40-item, self-report questionnaire that 
assesses an individual's perception of social support 
availability. Responders rate on a 4-point Likert-type 
scale how accurately each item describes their access to 
social support. The ISEL's development was influenced by 
the current notion that social support buffers the effect 
of stressful events (Cohen & Willis, 1985).
A total aggregate score and four subscale scores 
(appraisal, belonging, self-esteem, and tangible) are 
derived from the ISEL. Only the total score will be 
incorporated in the present study. Validation studies have 
indicated adequate concurrent (r = .46) and discriminant (r 
= -.64) validities (Cohen & Willis, 1985). Reliability of 
the ISEL is good, with test-retest coefficients averaging 
.87 for the total aggregate score (Cohen, Mermelstein, 
Kamarck, & Hoberman, 1985).
Wavs of Coping Questionnaire-Revised
(WCQ-R; Folkman & Lazarus, 1985). The WCQ-R is a 66- 
item questionnaire designed to assess coping strategies 
used during specific stressful events (e.g., medical 
procedures, exams). The authors conceptualize coping as a 
changing process, suggesting that coping strategies vary 
within a given individual as result of his/her appraisal of
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stress. The questionnaire was designed to assess the 
dynamics of coping rather than static coping styles or 
traits (Folkman & Lazarus, 1985). A factor analysis on the 
WCQ-R yielded eight factors that represent theoretically 
distinct, coping strategies (e.g., emotion-focused coping, 
problem-focused coping, social support utilization). From 
these factors, eight subscales were developed. In the 
present study, only the Problem-focused Coping subscale was 
used, as it demonstrates the best reliability (alpha=.85).
Center for Epidemiologic Studies Depression Scale
(CES-D; Radloff, 1977). The CES-D is a 20-item 
questionnaire that evaluates depression, with an emphasis 
on measuring affective symptomatology. Responses are 
scored on a 4-point Likert-type scale according to weekly 
occurrence ("0-rarely or none of the time/less than a day" 
to "3-most or all of the time/5 to 7 days").
The CES-D has demonstrated good reliability (split- 
half correlations: .77-.85; Spearman-Brown coefficients: 
.87-.92). Validation studies have been met with moderate 
results. Correlations with other depression measures have 
ranged from .37 to .90. Interviewer ratings correlate from 
.46 to .53 with the CES-D (Radloff, 1977).
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State-Trait Anxiety Inventory
(STAI; Speilberger, 1983). The STAI is a widely used 
self-report questionnaire measuring anxiety symptoms. Two 
forms, each with 20 items, comprise the STAI. The State- 
Anxiety (STAI-S) scale assesses an individual's current 
level of anxiety at the time of administration, while the 
Trait-Anxiety (STAI-T) scale evaluates the individual's 
general level of anxiety. The STAI-T scale was used in the 
present study.
Extensive findings on the stability and validity of 
the STAI-T scale have been reported (Speilberger, 1983). 
Reliability coefficients (test-retest) ranged from .70 to 
.76. A median alpha coefficient of .90 indicated that the 
STAI-T scale is internally consistent. Average correlation 
with other anxiety measures was .80, suggesting good 
concurrent validity.
Symptom Checklist for HIV Infection
(SCL-HIV; Gorman et al., 1991). Recently, a group of 
medical researchers designed a checklist to assess the 
degree of HIV symptomatology among their subjects. The 20- 
item checklist is composed of signs, symptoms, and common 
infections associated with HIV. Each item is given equal 
weight and a frequency score is generated. No data have 
been reported on the measurement properties of the SCL-HIV.
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T-Cell Count.
As part of their medical protocol, HIV patients 
undergo routine laboratory analyses of immune functioning. 
CD4 counts are considered the best indicator of disease 
progression in HIV and are monitored closely by medical 
professionals in order to regiment treatments (Bartlett & 
Finkbeiner, 1991). HIV-negative individuals have CD4 
counts averaging 1000 cells per milliliter of blood. 
Following HIV infection, CD4 counts decrease at a rate of 
approximately 85-100 cells per year. HIV-related symptoms 
are likely to develop when an individual's count drops 
below 300. CD4 counts typically range between 50-100 for 
AIDS patients (Bartlett & Finkbeiner, 1991).
Procedure
HIV-positive adults who were registered patients at the 
data collection sites were eligible to participate. During 
a clinic appointment when HIV patients were having blood 
drawn for T-cell counts, attending hospital staff informed 
potential subjects about the study and asked if they were 
interested in participating. If subjects volunteered, they 
signed informed consents explaining the nature of the study 
and allowing the experimenter access to their medical 
charts. Medical charts were reviewed to document 
laboratory results and other medical data (e.g., 
medications, diagnoses).
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All data were collected on the day of the clinic 
appointment. A graduate research assistant gathered a 
brief demographic and medical history. Following the 
history, subjects completed questionnaires on stress, 
social support, coping, and mood. As part of their routine 
medical protocol, subjects had blood drawn and sent to a 
laboratory. Immune parameters were analyzed from the blood 
sample, and an immune profile was later documented in each 




Descriptive statistics were calculated on demographic 
and experimental variables. Profiles of the sample's 
demographic and experimental characteristics are presented 
in Tables 1, 2, and 3. Mean scores of the psychosocial 
variables revealed significant affective distress in the 
sample. The mean CES-D depression score (22.4) is clearly 
above the cut-off score (16) indicative of clinical 
depressive symptomatology. Similarly, STAI-T mean anxiety 
score (45.7) approached the 90th percentile for normal 
adults.
Several relations between demographic and outcome 
variables were statistically significant. T-tests revealed 
a few significant sex differences. Males had been 
diagnosed HIV-positive longer than females [t (99)=2.49, 
p=.014], and females had higher total T-cell counts 
[t (95)=-1.99, £=.049]. Female subjects also reported 
greater trait anxiety [t(95)=-2.40, p=.018].
T-tests were conducted to examine racial differences 
across all experimental variables. Race was dummy-coded, 
dividing the sample into two groups - Caucasians (n=33) and 
racial minorities (n=67). Caucasians reported higher major 
stress scores [t (100)=2.53, p=.013], endorsed more HIV- 
related symptoms [t(97)=2.85, p=.005], and had been
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Table 1
Demographic Variables: Descriptive Statistics









Age (years) 32.6 18-54 7.4
Education (years) 12.2 6-21 2.5
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Table 2
Sample Demographics by Site
Louisiana State University Medical Center;







Age (years) 31.7 18-52 7.1
Education (years) 11.9 6-19 2.4
University of Southern California Medical Center:
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diagnosed HIV-positive longer [t(99)=2.58, £=.011] than 
racial minorities.
Correlational Statistics 
Pearson product-moment correlations were generated for 
age and education across all experimental variables. Older 
subjects had been diagnosed HIV-positive longer (r=.20, 
£=.049) and had fewer CD4 cells (r=-.24, g=.020). Years of 
education was significantly correlated with anxiety (r=- 
.23, p=.026) and depression (r=-. 26, £=.010), both in 
negative directions. Years of education also significantly 
correlated with illness duration (r=.2 2, £=.026).
A correlational matrix of Predictor by Outcome 
variables was generated and the results can be found in 
Table 4. Only one predictor variable, problem-focused 
coping, significantly correlated with total CD4 count (r=- 
.214, £=.04) but in the unexpected direction. No other 
predictor variable significantly correlated with CD4 count. 
Problem-focused coping also significantly predicted HIV 
symptom count, but again in the unexpected direction 
(r=.310, £=.002).
All remaining predictor variables correlated with HIV 
symptom count in statistically significant and expected 
directions. HIV symptoms positively correlated with both 
major stress (r=.210, £=.039) and minor stress (r=.238, 
£=.02). Social support correlated negatively with HIV
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Table 4
Correlational Matrix of Predictor X Outcome Variables
Total CD4 # of HIV
Count___________Symptoms
# of months HIV+ -.119 .181
Major Stress -.039 .210*
(SRRS)
Minor Stress -.038 .238*
(WSI)
Problem-focused Coping -.214* .310**
(WCQ-R)








symptoms (r=-.294, p=.004). HIV symptom count correlated 
positively with both mood variables, anxiety (r=.275, 
p=.007) and depression (r= = 290, p=.004)
Structural Analyses 
To further test main hypotheses of the present study, 
a linear structural analysis was performed on the model 
proposed in Figure 1 (see page 33). The EQS program 
(Bentler, 1989) was used to conduct the analysis. In the 
model, an arrow indicates the direct effect of one variable 
on another. Direct effects were represented statistically 
by path coefficients, i.e. beta weights (B).
From the analysis, indirect and total effects were 
calculated. An indirect effect is the influence of one 
variable on another that is transmitted via an intermediate 
variable(s). Numerically, it is the product of the path 
coefficients that make up the nondirect links between two 
variables. For example, in the proposed model, the 
indirect effect of social support on HIV disease = (social 
support's direct effect on mood) X (mood's direct effect on 
HIV disease). Total effects then were calculated by 
summing direct and indirect effects (Bentler, 1990).
Data have indicated that duration of infection is the 
only consistent predictor of HIV disease progression 
(McDougal et al. 1989). Therefore, illness duration 
(number of months HIV-positive) was entered first into the
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model to control for current stage of HIV disease 
progression. Surprisingly, however, duration of infection 
was not significantly correlated with either CD4 count (r=- 
.119, ns) or HIV symptom count (r=.181, ns).
Following illness duration, variable entry into the 
model occurred according to the following logics Given 
that minor stress may exhibit a greater influence on 
disease than major stress (Delongis et al, 1982), major 
stress preceded minor stress in building the model.
Because both have been observed to mediate stress effects, 
coping and social support followed stress and were entered 
simultaneously into the model. Anxiety and depression may 
result from a combination of inordinate stress, faulty 
coping strategies, and/or lack of social support (Cohen & 
Wills, 1985). Thus, anxiety and depression were collapsed 
to form the latent variable "mood" which was entered next 
into the model. Finally, symptoms, CD4 count, and CD4/CD8 
ratio were combined to form "HIV disease," the model's 
latent outcome variable.
To test how well the overall model fit the data, four 
indices were generated. The indices suggested the data did 
not fit the model well - Chi-square (23, N=100) = 47.28, 
p>.002, Bentler/Bonnet Normed Fit Index = .87, Bentler- 
Bonett Nonnormed Fit Index = .85, and Comparative Fit Index 
= .93. The model's latent outcome variable, "HIV disease", 
received statistically significant loadings from total CD4
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count and CD4/CD8 ratio (-.89 and -.84, respectively) but 
not from HIV symptoms (.49).
A second model (see Figure 2) was constructed omitting 
the two T-cell outcome variables. HIV symptom count 
comprised the only disease outcome variable in the second 
model. Additionally, because illness duration did not 
predict the latent variable "HIV disease" in the original 
model or correlate individually with CD4 count or symptoms, 
it was excluded as a control variable in the second model. 
The second model fit the data extremely well. All 
statistical fit indices highly supported the model - Chi- 
squared (5, W=100) = 1.396, p= o 92; Bentler-Bonett Normed 
Fit Index = .99; Bentler Bonnett Nonnormed Fit Index = 1.0; 
Comparative Fit Index = 1.0. Direct effects and percent 
variances of the psychosocial variables on HIV symptoms are 
listed in Table 5. Direct effects and percent variances of 
stress, social support, and coping on mood are listed in 
Table 6.
In the second model, coping (direct effect = .263,
E < .05) and mood (direct effect = .226, p <  .05) 
significantly impacted HIV symptoms. Neither of the stress 
variables nor social support predicted HIV symptoms.
However, minor stress (direct effect = . 424 , p<.01) and 
social support (direct effect = -.428, p < .05)
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demonstrated significant effects on the latent variable, 



























Direct Effects and %Variances of Psychosocial Co­-factors
on HIV Symptoms in HIV Svrnptom-Onlv Structural Model
Variable direct effect %variance
Major Stress .088 0.7
Minor Stress -.073 0.5
Problem-focused
Coping .263* 6.9





Direct Effects and %Variances of Stress, Social Support.
and Cooincr on Mood in HIV Svmntom-Onlv
W V W X l * * U U H H W 4 . U I
Structural Model
Variable direct effect %variance
Major Stress .111 1.2
Minor Stress .424* 18.0
Problem-focused
Coping -.113 1.3
Social Support -.428* 18.3
(Total) 38.8
DISCUSSION
The results suggest the originally proposed structural 
model did not represent the data in a statistically 
significant fashion. Despite failure of the model, Pearson 
product-moment correlations revealed a strong association 
between each of the proposed psychosocial co-factors and 
number of HIV-related symptoms. This trend, however, was 
not observed in relations among the same psychosocial 
variables and T-cell counts. With these results in mind, a 
second model was constructed to illustrate the impact of 
the psychosocial variables on HIV symptom count alone, 
excluding the immunological measures. The second model was 
highly significant with psychosocial co-factors accounting 
for 15% of the variance in HIV symptoms.
Lack of significance in the original model can be 
explained theoretically and statistically. Theoretically, 
the manifest variables (HIV symptom count and T-cell 
counts) selected to constitute the latent variable "HIV 
disease" may not have been the best or only choices. 
Pathophysiology of HIV disease is highly variable, complex, 
and unpredictable (Rogers & Masur, 1989). Additional 
disease manifestations (e.g., natural killer cell count and 
opportunistic infections not included in the SCL-HIV) may 
be equally important in describing HIV illness as a 
construct. Bentler and Chou (1987) have emphasized a major 
theoretical limitation of structural modeling is that key
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variables often are omitted when designing a model.
Breckler (1990) encourages the exploration of alternate 
models when using structural modeling procedures.
In the original model, CD4 count (-.89) and CD4/CD8 
ratio (-.84) loaded highly on the latent variable "HIV 
disease" whereas symptoms (.49) did not. Statistically, 
the model attempted to maximize the variance of "HIV 
disease" as a construct. As a result, the model mainly 
predicted T-cells. HIV symptoms were not captured well by 
the latent variable "HIV disease" and the overall model was 
invalidated.
Although none of the psychosocial variables were 
linked to T-cell counts, a few demographic variables 
correlated significantly with T-cells. Lower T-cell counts 
were associated with increased age and being male. These 
findings were not surprising given that males and older 
subjects in this sample had significantly longer illness 
duration. Additionally, age is associated with a poorer 
prognosis and accelerated HIV disease activity (Cohen, 
Salde, & Volberding, 1990). Although sex is considered to 
be a potential co-factor in HIV by some authors 
(Rothenberg, Woelfel, Stoneburner, Milberg, Parker, & 
Truman, 1987), the relatively small female sample size 
(n=20) does not permit valid interpretations of sex 
differences from the present study.
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Collectively, health professionals appear perplexed 
when discerning what factors predict HIV disease course. No 
consistent pattern of HIV disease progression has been 
defined (Gorman & Kertzner, 1990). A similar enigma 
challenging researchers is identifying co-factors that 
predict mortality and/or longevity. Researchers are 
beginning to explicate reasons why long-term AIDS survivors 
remain alive and healthy despite depleted T-cells and over 
a decade of seropositivity (Solomon, Temoshok, O'Leary & 
Zich, 1987) . Numerous co-factors including nutrition, 
repeated exposure to HIV, presence of concomitant viruses, 
genetic make-up, and psychosocial co-factors have been 
hypothesized with varying degrees of empirical support 
(Gorman & Kertzner, 1990; Livingston, 1988; Watson, 1990).
To date, data supporting an association between 
psychosocial co-factors and immunological markers in HIV 
remain inconclusive. Consistent with the present results, 
the majority of recently published studies have not 
supported a strong relationship between psychosocial co­
factors and T-cell counts. Sahs et al. (1993) reported no 
significant effects for psychological distress or presence 
of comorbid psychiatric disorders on immune profiles in a 
cross-sectional study of 120 HIV-positive individuals. Two 
prospective studies, both with sample sizes over 100, also 
failed to find significant associations between multiple 
psychosocial variables and T-cell counts. Nevertheless,
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both studies reported significant relations between the 
same psychosocial variables (i.e. stress, depression, 
anxiety, social support, hardiness, psychiatric 
symptomatology, grief, and hopelessness) and number of HIV 
symptoms (Perry, Fishman, Jacobsberg & Frances, 1992;
Rabkin et al., 1991).
Of the psychosocial variables in the present study, 
coping and mood demonstrated the strongest association with 
HIV symptomatology. Significant influences of coping and 
mood on HIV symptoms were evidenced in both the 
correlational matrix and the symptom-only structural model. 
The impact of coping on HIV symptoms, however, occurred in 
the unexpected direction. That is, as problem-focused 
coping increased, so did the number of symptoms. One 
explanation for this finding may be the questionable 
validity of the subscale. Development and validation of 
the WCQ-R appear to be in the infancy stages. The Problem- 
focused subscale is only 12 items, and no information on 
its content validity is available. Additionally, no 
concurrent or discriminant validity studies on the WCQ-R or 
Problem-focused subscale have been reported.
Another explanation for the link between coping and 
HIV symptoms concerns what Bentler and Chou refer to as a 
"nonrecursive” model. In nonrecursive models, the 
directionality of influence between certain pairs of 
variables may be two-way. In the symptom-only model, the
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connection between coping and symptoms may be more 
accurately represented by a double-headed arrow. The 
relationship may indeed be significant, with problem- 
focused coping being a response to exacerbations in HIV 
illness as well as an antecedent. Administration of WCQ-R 
supports this explanation. When responding, subjects were 
asked to rate how they coped with HIV specifically. They 
did not report on general coping style.
The impact of mood on HIV disease status has been 
documented in previous studies. In the present study, 
increased anxiety and depression were associated with 
higher HIV symptom counts. Although data supporting an 
association between affective distress and immune 
parameters remains inconclusive in the current literature 
(Mulder & Antoni, 1991), the present results add to the few 
available studies (Ostrow et al., 1989; Perry, Fishman, & 
Jacobsberg, 1992; Rabkin et al., 1991; and Temoshok, 
O'Leary, & Jenkins, 1990) suggesting mood significantly 
impacts HIV symptomatology. Future studies could expand 
current literature by including additional affective 
variables (e.g, hostility) and examining the differential 
effects of particular mood states on HIV disease.
The correlational matrix provided evidence that major 
stress, minor stress, and social support significantly 
correlate with the number of HIV symptoms. In the symptom- 
only model, however, none of these variables exhibited
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significant effects on HIV symptomatology. It appears from 
the model that minor stress and social support have 
significant indirect effects on HIV symptoms via mood, as 
both minor stress and social support significantly impacted 
mood in the model. Thus, the impact of minor stress and 
social support on HIV symptoms may be substantial but is 
likely mediated by anxiety and/or depression.
The present findings revealed no differential effects 
of major stress versus minor stress on HIV disease status. 
However, minor stress had a significant impact on mood 
whereas major stress did not. This datum supports the 
notion that minor stress exhibits a greater influence than 
major stress on global health (Brantley & Jones, 1989; 
Delongis et al., 1982). Moreover, with the effect of 
social support on mood controlled, the effect of minor 
stress on mood remained significant in the symptom-only 
model. This finding suggests social support does not 
buffer the effect of stress on mood in HIV-positive 
individuals.
As expected, increased minor stress and decreased 
social support availability were significantly linked to 
elevations in anxiety and depression. Together, minor 
stress and social support accounted for 36% (18% each) of 
mood variance in the symptom-only model. Major stress and 
problem-focused coping, however, demonstrated no 
significant effects on mood. Therefore, the roles of major
61
stress and problem-focused coping in HIV-positive 
individuals' affective regulation remain unclear.
As previously mentioned, a concern when employing 
structural modeling is that important variables may be 
omitted that better explain the constructs. Numerous 
medical co-factors (e.g., nutrition, viral load, presence 
of other illnesses) have been purported to contribute to 
the HIV illness spectrum (Watson, 1990). There may be 
additional psychosocial co-factors, aside from the ones in 
the present study, that are paramount in describing the 
psychosocial-HIV nexus.
High risk behaviors constitute an important category 
of psychosocial influences on HIV not included in the 
present study. Recently, data have supported the idea that 
increased stress is associated with unsafe sexual practices 
(Folkman, Chesney, Pollack, & Phillips, 1992; Coates, 
McKusick, Kuno, & Stites, 1989) and intravenous drug use 
(Hartgers, Vanden-Hoek, Coutinho, & Vander-Pligt, 1992) 
among HIV-positive individuals. That is, when stressed, 
individuals engaged in high risk behaviors more frequently. 
Collectively, these studies indicated high risk behaviors 
may mediate stress' impact on repeated exposure to the 
virus. Repeated exposure to additional and perhaps more 
virulent HIV strains is considered a possible co-factor in 
the progression of HIV disease (Sonnabend, Witkin &
Purtilo, 1984).
CONCLUDING REMARKS
The present results add to a growing literature 
suggesting certain psychosocial co-factors contribute to 
the progression of HIV disease. These findings have 
important implications for the direction of future 
psychosocial HIV research. Biopsychosocial models provide 
a valuable heuristic when studying illness. The structure 
of the present model was theoretically derived and 
empirically supported. As the connection between 
psychosocial co-factors and HIV disease status becomes more 
evident, investigators should attempt to identify alternate 
models and additional mechanisms for this nexus.
Psychoneuroimmunological research has provided strong 
evidence for the interrelationships among various 
psychological states, neurochemicals, and immunological 
parameters in normal human and animal subjects (Ader,
1991). Based on these data, Solomon, Kemeny, and Temoshok
(1991) authored a comprehensive review, hypothesizing 
probable psychoneuroimmunological pathways in HIV.
Evidence supporting an association between biological 
markers of psychological distress (e.g., corticosteroids, 
neuropeptides, and catecholamines) and HIV pathophysiology 
are sparse but are beginning to emerge in the literature 
(Antoni et al., 1990; Gorman et al., 1992; Gorman et al.). 
These data increase objectivity and provide stronger 
support for biopsychosocial models of HIV. Given the
62
63
present findings, researchers should continue to 
investigate HIV psychoneuroimmunology as it relates to HIV 
symptom expression.
As health professionals recognize biopsychosocial 
models of HIV with more confidence, implications for mental 
health services in the treatment of HIV become paramount. 
Applied researchers are beginning to offer evidence for the 
efficacy of psychotherapeutic approaches in managing HIV 
disease (Antoni et. al., 1991; Coates, McKusick, Kuno, & 
Stites, 1989; LaPerriere et al., 1990). Given the chosen 
psychosocial variables in the present study, stress 
management and support groups may be important treatment 
strategies for combatting the high morbidity of affective 
disorders in individuals with HIV. Moreover, the present 
findings support the notion that mood management and 
alterations in coping style may attenuate HIV 
symptomatology.
Perhaps the most cardinal contribution of the present 
study concerns the sample demographics. The sample 
overincluded females (20% of the sample) and African- 
Americans (59% of the sample), relative to the U.S. 
prevalence of HIV-positive individuals in these groups (11% 
and 30%, respectively). Hispanics (7% of the sample) also 
were included but did not match the U.S. prevalence of 17%. 
Ninety-five percent of the sample had annual incomes 
totaling less than $10,000 per year.
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These sample characteristics have several important 
implications. First, HIV research in general has been 
criticized for including primarily Caucasian, 
socioeconomically stable, homosexual/bisexual males. HIV 
studies that include minorities, females, and the 
economically challenged are a rarity. Demographic 
heterogeneity in the sample makes the results more 
generalizable and represents a large portion of the U.S.
HIV population long ignored by research efforts.
Second, although insufficient and unbalanced sample 
sizes prevented appropriate statistical comparisons of race 
and sex in the present study, data identifying race and sex 
as important co-factors in predicting survival among HIV- 
positive individuals are emerging. Poorer prognosis among 
AIDS patients has been shown to be associated with African- 
American race (Reillo, 1990; Rothenberg, Woelfel, 
Stoneburner, Milberg, Parker, & Truman, 1987) and being 
female (Rothenberg et al., 1987). Future studies should 
continue to address ethnic and sex differences as they 
relate to the progression and treatment of HIV disease.
Finally, as a result of education and prevention 
efforts among the gay/lesbian community, the prevalence of 
HIV infection among homosexual males relative to other risk 
groups is declining (Nash & Said, 1992; Winkelstein & 
Padian, 1987). Unfortunately, infection rates among the 
other risk groups that include minorities, women, and the
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economically challenged in large proportions are rising 
dramatically (Nash & Said, 1992). The present findings 
justify meeting the ever-present demands for increased 
research agendas, treatments, and prevention efforts 
targeting these special populations.
In summary, the present study supported the contention 
that psychosocial co-factors influence disease status in 
HIV-positive individuals. The results indicated 
psychosocial co-factors contributed to symptom expression 
but not immune functioning in HIV-positive individuals. 
Coping and mood were observed to have substantial direct 
impacts on HIV symptomatology. Stress and social support 
contributed to the overall health of HIV-positive 
individuals by their significant effects on mood. Given 
that major stress did not have significant direct or 
indirect effects on HIV symptoms, eliminating major stress 
from the model would improve its parsimony.
The results validated a model illustrating the 
interrelations among psychosocial co-factors and HIV. 
However, as statisticians have indicated, alternate models 
may explain the data equally well or better (Bentler &
Chou, 1987). Future investigative efforts should continue 
to replicate the present results as well as look for 
alternate models to explain the links among psychosocial 
co-factors and HIV. Including other psychosocial 
predictors, such as frequency of high risk behaviors, may
account for additional variance in HIV disease. Disease 
parameters not included in the present study, such as 
natural killer cell count and opportunistic infections not 
captured by the SCL-HIV, may improve validity of the model 
as well.
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